VICKIE L CAPPS
CIK 1248190 · Executive VP, CFO · last filed 2026-06-12
VICKIE L CAPPS is an Executive VP, CFO who has filed 64 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for JANX, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$794.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.72M
10
64
$794.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JANX | Director | 79,598 | $15.00 | $1.19M | $0 | 7 | 2026-06-12 |
| OFIX | Director | 43,300 | $12.26 | $530.9K | $62.3K | 4 | 2026-06-12 |
| AMEDISYS INC (AMED) Delisted | Director | 0 | $100.99 | $0 | $187.0K | 9 | 2025-08-14 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $96.5K | 11 | 2023-09-05 |
| OTONOMY, INC. (OTIC) Delisted | Director | 5,000 | $0.08 | $385 | $117.4K | 11 | 2022-11-29 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | 61,576 | $5.87 | $361.5K | $200.0K | 4 | 2022-06-13 |
| Synthorx, Inc. (THOR) Delisted | Director | — | — | — | $0 | 2 | 2020-01-24 |
| CONNECTURE INC (CNXR) Delisted | Director | 136,898 | — | — | $24.1K | 5 | 2017-05-25 |
| SENORX INC (SENO) Delisted | Director | 15,652 | — | — | $72.8K | 5 | 2010-07-07 |
| DJO INC (PXR) Delisted | Executive VP, CFO | 32,837 | — | — | $34.6K | 4 | 2007-05-30 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | JANX | Grant (A) | +5,500 | $0 | EDGAR |
| 2026-06-12 | OFIX | Grant (A) | +14,965 | $0 | EDGAR |
| 2026-03-10 | OFIX | Buy (P) | +5,000 | $62.3K | EDGAR |
| 2025-08-14 | AMEDISYS INC (AMED) Delisted | Disp (D) | −9,818 | $0 | EDGAR |
| 2025-06-23 | OFIX | Grant (A) | +18,841 | $0 | EDGAR |
| 2025-06-13 | JANX | Grant (A) | +3,750 | $0 | EDGAR |
| 2025-05-06 | AMEDISYS INC (AMED) Delisted | Grant (A) | +1,690 | $0 | EDGAR |
| 2025-03-13 | OFIX | Grant (A) | +3,093 | $0 | EDGAR |
| 2024-11-07 | JANX | Other (J) | +2,305 | $0 | EDGAR |
| 2024-06-28 | JANX | Grant (A) | +2,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.